Results 131 to 140 of about 146,858 (317)
Headache: The Journal of Head and Face Pain, EarlyView.Abstract Objective The aim of this study was to evaluate the efficacy and safety of a 60‐day peripheral nerve stimulation (PNS) treatment targeting the occipital nerves for reducing pain and improving function in individuals diagnosed with cervicogenic headache or occipital neuralgia. Background Headache conditions are prevalent and commonly disabling,
Genaro G. Gutierrez +11 more
wiley +1 more source
A retrospective study of 72 cases diagnosed with idiopathic trigeminal neuralgia in indian populace [PDF]
, 2015 Context: Trigeminal neuralgia is as a chronic, debilitating condition, which can have a major impact on quality of life. There are few reports of trigeminal neuralgia in oriental populations. Objectives: To evaluate the retrospective data of the patients
Dhupar, Anita +5 more
core +1 more source
Long‐term evolution of white and gray matter structural properties in migraine
Headache: The Journal of Head and Face Pain, EarlyView.Abstract Objective To elucidate the specific brain changes linked to clinical diagnoses and distinct temporal progression in migraine. Background Gray (GM) and white matter (WM) differences were previously identified in chronic migraine (CM) compared to episodic migraine (EM).
Álvaro Planchuelo‐Gómez +5 more
wiley +1 more source
Headache: The Journal of Head and Face Pain, EarlyView.Abstract Background and Objectives Carbamazepine is commonly used as the first‐line treatment for trigeminal neuralgia, but therapeutic failure due to adverse effects is frequent. While various second‐line alternatives have been suggested, there is limited evidence directly comparing these options.
Albert Muñoz‐Vendrell +5 more
wiley +1 more source
Internal Medicine Journal, EarlyView.Abstract Background and Aim Varicella zoster virus (VZV) is a neurotropic herpesvirus. With improved access to molecular diagnostics, there is increasing recognition of VZV with central nervous system involvement. This study aimed to describe the demographic, clinical and treatment characteristics of patients admitted to an Australian tertiary hospital
Connie Lam +6 more
wiley +1 more source
Current status and future directions of botulinum neurotoxins for targeting pain processing. [PDF]
, 2015 Current evidence suggests that botulinum neurotoxins (BoNTs) A1 and B1, given locally into peripheral tissues such as skin, muscles, and joints, alter nociceptive processing otherwise initiated by inflammation or nerve injury in animal models and humans.
Pellett, Sabine +2 more
core +2 more sources